期刊文献+

癌症基因治疗技术进展与展望 被引量:6

Progress and Prospect of Cancer Gene Therapy
原文传递
导出
摘要 癌症是严重危害人类健康的重大疾病之一,寻找高效可行的癌症治疗方法一直是医学研究的重要课题。继外科手术、放疗、化疗、免疫治疗之后,随着人们对基因组学的深入了解及分子生物学技术的不断发展,基因治疗作为一种全新的治疗理念已被证明具有显著临床疗效及优势。对癌症基因治疗的原理及几种新技术的应用进行介绍,并对基因治疗未来在临床上的应用加以展望。 Cancer is becoming one of the major diseases with serious hazards to human health. To find efficient treatment protocols has always been the important subject in cancer studies. While surgical management,radiotherapy,chemotherapy and immunotherapy have achieved certain effects,there are distinct limits in each method. With the development of data mining methods and molecular experimental technologies,more and more cancer related targets and signaling pathways were discovered from human genome. Based on such knowledge,gene therapy has been proved to be with significant efficacy and superiorities in both experimental and clinical trials. The principle of gene therapy and some recent technologies in cancer gene therapy were summarized. Then the prospects of cancer gene therapy in future clinical application were discussed.
出处 《中国生物工程杂志》 CAS CSCD 北大核心 2016年第5期106-111,共6页 China Biotechnology
基金 西藏自治区高校青年教师创新支持计划(QC2015-25) 西藏大学研究生高水平人才培养项目(2015-GSP-001)资助项目
关键词 基因治疗 靶向基因-病毒治疗 RNA干扰 微小RNA CRISPR/Cas9技术 Gene therapy Cancer targeting gene-viro-therapy RNA interference miRNA CRISPR/Cas9
  • 相关文献

参考文献6

二级参考文献90

  • 1Hao Liu,Shou-Jun Yuan,Ying-Tai Chen,Yi-Bin Xie,Liang Cui,Wei-Zhi Yang,De-Xuan Yang,Yan-Tao Tian.Preclinical evaluation of herpes simplex virus armed with granulocyte-macrophage colony-stimulating factor in pancreatic carcinoma[J].World Journal of Gastroenterology,2013,19(31):5138-5143. 被引量:4
  • 2许文林,沈慧玲,袁伟,江云伟,阮长耿.血管内皮细胞生长因子受体短发夹环RNA真核表达载体的构建[J].苏州大学学报(医学版),2004,24(4):479-483. 被引量:3
  • 3张太平,赵玉沛.胰腺癌的分子生物学特性及治疗进展[J].中华外科杂志,2007,45(1):43-44. 被引量:4
  • 4Endlicher E,Troppmann M, Kullmann A, et al. lrinotecan plus gemcitabine and 5-fluorouracil in advanced pancreatic cancer: a phase II study. Oncology,2007 ,72 :279-284.
  • 5Arh A ,Gehvz A,Mtierkoster S ,et al. Role of NF-kB and Akt/P13K in the resistance of pancreatic carcinoma cell lines against gemcitabine-induced cell death. Oncogene, 2003,22 : 3243-3251.
  • 6Guo J, Verma UN, Gaynor RB,et al. Enhanced chemosensitivity to irinotecan by RNA interference mediated down-regulation of the nuclear factor-kB p65 subunit. Clin Cancer Res,2004,10: 3333- 3341.
  • 7Tang ZY,Wu YL, Gao SL, et al. Effects of the proteasome inhibitor hortezomih on gene expression profiles of pancreatic cancer cells. J Surg Res,2008,145 : 111-123.
  • 8Beger HG, Rau B, Gansauge F, et al. Treatment of pancreatic cancer: challenge of the facts. World J Surg,2003 ,27 :1075-1084.
  • 9Duxbury MS, Ito H, Zinner MJ, et al. RNA interference targeting the M2 subunit of ribonueleotide reductase enhances pancreatic adenoeareinoma ehemosensitivitv to gemcitabine. Oneogene,2004, 23:1539-1548.
  • 10Kunnumakkara AB, Guha S, Krishnan S, et al. Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor-KB-regulated gene products. Cancer Res ,2007,67:3853-3861.

共引文献84

同被引文献48

引证文献6

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部